HemoGenyx Pharmaceuticals Plc(GB:HEMO)
GBX 680.00+56.00 (+8.97%)
GB:HEMO
HemoGenyx Pharmaceuticals Plc financials statements
GBX 680.00
At close:+56.00 (+8.97%)
Want to see GB:HEMO full AI Analyst Report?
HemoGenyx Pharmaceuticals Plc (HEMO) Income Statement
37 Followers
HemoGenyx Pharmaceuticals Plc Income Statement
Last quarter (Q2 2026), HemoGenyx Pharmaceuticals Plc's total revenue was £0.00. In Q2, HemoGenyx Pharmaceuticals Plc's net income was £-6.55M. See HemoGenyx Pharmaceuticals Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | |
| £ -588.75K | £ -639.28K | £ -645.68K | £ -2.60M | £ -283.65K | |
| £ 4.07M | £ 5.09M | £ 4.91M | £ 2.93M | £ 2.70M | |
| Depreciation and Amortization | £ 588.75K | £ 639.28K | £ 645.68K | £ 564.07K | £ 126.34K |
| £ -4.07M | £ -4.71M | £ -5.73M | £ -3.42M | £ -2.39M | |
| £ -4.66M | £ -5.73M | £ -5.56M | £ 4.00M | £ -2.70M | |
| £ -5.11M | £ 101.22K | £ -1.14M | £ 1.54M | £ -2.41M | |
| £ -9.77M | £ -5.63M | £ -6.70M | £ -3.99M | £ -5.11M | |
| £ -9.76M | £ -5.62M | £ -6.69M | £ -3.98M | £ -5.10M | |
| Per Share Metrics | |||||
| Basic EPS | £ -2.20 | £ -1.70 | £ -2.37 | £ -1.62 | £ -2.64 |
| Diluted EPS | £ -2.20 | £ -1.70 | £ -2.37 | £ -1.62 | £ -2.64 |
| Weighted Average Shares Outstanding | 4.44M | 3.30M | 2.82M | 2.45M | 1.93M |
| Weighted Average Shares Outstanding (Diluted) | 4.44M | 3.30M | 2.82M | 2.45M | 1.93M |
Currency in GBP
